TAVR replaces the damaged aortic valve without the need for open-heart surgery. In this procedure, doctors insert a thin, ...

It’s a serious heart defect that can cause blood to flow into the wrong part of the heart chamber, and up until recently, it ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

JP Morgan upgraded Edwards Lifesciences (EW) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replacement (TAVR) division and strength in its transcatheter ...

Among patients undergoing TAVR, the characteristics and mechanisms causing atrioventricular (AV) conduction block during the procedure differed from those after the procedure, according to a study ...

The Sapien 3 Ultra Resilia transcatheter aortic valve replacement system. [Image courtesy of Edwards Lifesciences] CMS has accepted a request from Edwards Lifesciences (NYSE: EW) + for a new coverage ...

Edwards Lifesciences has persuaded CMS to publish an updated tracking sheet for TAVR national coverage analysis. The move is causing CMS to reconsider its previous stance on covering transcatheter ...

The Centers for Medicare and Medicaid Services will reconsider its national coverage determination for transcatheter aortic valve replacement in response to a request from Edwards Lifesciences, ...